Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05841628 · ClinicalTrials.gov registry record · NA
Tolerability of 532 nm Laser Treatment of Port Wine Stains
A NA study of Port-Wine Stain, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT05841628 is a NA study of Port-Wine Stain that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 15 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05841628, a NA study of Port-Wine Stain, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to learn about treatment of port wine birthmarks treated with an FDA-approved 532 nm laser. The main questions it aims to answer are: * How well are the treatments tolerated? * Are there differences in tolerability of the treatment when a single high fluence laser pulse is used (the standard treatment) versus using multiple low fluence pulses? * Are there differences in results when using a single high fluence pulse versus multiple low fluence pulses? type of study: Clinical Trial Participants will undergo 3 monthly laser treatments with the 532 nm DermaV laser. Part of their birthmark will be treated with the standard single-pulse high fluence approach, and other parts will be treated with the multiple-pulse low fluence approach.
Conditions Studied
Interventions
- DEVICE 532 nm laser treatment
Study Locations (1)
Massachusetts
- Wellman Center for Photomedicine, Harvard Medical School - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2023-05-01 |
| Est. Completion | 2026-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05841628
The ClinicalTrials.gov registry entry for NCT05841628 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Port-Wine Stain appearing as the primary indexed condition, and to 1 intervention - of which 532 nm laser treatment is the first listed.
NCT05841628 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05841628 about?
NCT05841628 is a clinical study titled "Tolerability of 532 nm Laser Treatment of Port Wine Stains". The goal of this study is to learn about treatment of port wine birthmarks treated with an FDA-approved 532 nm laser. The main questions it aims to answer are: * How well are the treatments tolerated? * Are there differences in tolerability of the treatment when a single high fluence laser pulse i...
What is the current status of trial NCT05841628?
This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2023-05-01. Estimated completion is 2026-12.
What conditions does trial NCT05841628 study?
This clinical trial studies the following conditions: Port-Wine Stain.
What interventions are being tested in trial NCT05841628?
The interventions under investigation include: 532 nm laser treatment (DEVICE).
Who is sponsoring clinical trial NCT05841628?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05841628 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Port-Wine Stain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.